ProfileGDS4718 / 217554_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 47% 71% 41% 38% 51% 46% 40% 42% 42% 32% 42% 33% 46% 45% 41% 44% 41% 40% 36% 33% 40% 43% 40% 39% 43% 44% 43% 42% 41% 43% 44% 45% 40% 46% 41% 43% 43% 38% 67% 39% 40% 48% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.065141
GSM549102patient 115, normal, homogenized [OPG study]5.3703247
GSM549104patient 119, normal, homogenized [OPG study]7.0227371
GSM549108patient 138, normal, homogenized [OPG study]5.0796641
GSM549119patient 077, normal, homogenized [OPG study]4.9261438
GSM549133patient 032, cancer, homogenized [OPG study]5.5123351
GSM549139patient 042, cancer, homogenized [OPG study]5.2626146
GSM549099patient 107, normal, homogenized [OPG study]5.0146340
GSM549109patient 139, normal, homogenized [OPG study]5.1174542
GSM549110patient 046, normal, homogenized [OPG study]5.0981742
GSM549114patient 063, normal, homogenized [OPG study]4.5638432
GSM549122patient 082, normal, homogenized [OPG study]5.0990342
GSM549134patient 033, cancer, homogenized [OPG study]4.648433
GSM549136patient 036, cancer, homogenized [OPG study]5.2570246
GSM549140patient 044, cancer, homogenized [OPG study]5.1870445
GSM549111patient 047, normal, homogenized [OPG study]5.0168341
GSM549113patient 057, normal, homogenized [OPG study]5.136444
GSM549132patient 031, cancer, homogenized [OPG study]5.0214841
GSM549137patient 038, cancer, homogenized [OPG study]4.9835440
GSM549142patient 047, cancer, homogenized [OPG study]4.9319236
GSM549100patient 110, normal, homogenized [OPG study]4.7060833
GSM549107patient 135, normal, homogenized [OPG study]4.9688340
GSM549115patient 068, normal, homogenized [OPG study]5.0760743
GSM549116patient 072, normal, homogenized [OPG study]4.9700540
GSM549120patient 078, normal, homogenized [OPG study]4.9400539
GSM549131patient 030, cancer, homogenized [OPG study]5.0913243
GSM549118patient 074, normal, homogenized [OPG study]5.1836844
GSM549129patient 027, cancer, homogenized [OPG study]5.1430943
GSM549123patient 088, normal, homogenized [OPG study]5.0769442
GSM549124patient 006, cancer, homogenized [OPG study]5.0868641
GSM549126patient 015, cancer, homogenized [OPG study]5.1474843
GSM549128patient 025, cancer, homogenized [OPG study]5.1446544
GSM549103patient 117, normal, homogenized [OPG study]5.3165945
GSM549117patient 073, normal, homogenized [OPG study]4.9779140
GSM549138patient 041, cancer, homogenized [OPG study]5.261646
GSM549141patient 045, cancer, homogenized [OPG study]4.9608441
GSM549130patient 028, cancer, homogenized [OPG study]5.1552443
GSM549101patient 111, normal, homogenized [OPG study]5.1978143
GSM549105patient 128, normal, homogenized [OPG study]4.9355438
GSM549106patient 134, normal, homogenized [OPG study]6.7056467
GSM549112patient 048, normal, homogenized [OPG study]4.9174639
GSM549125patient 011, cancer, homogenized [OPG study]4.9851840
GSM549127patient 024, cancer, homogenized [OPG study]5.4259548
GSM549135patient 035, cancer, homogenized [OPG study]5.3283747